文献速递心脑血管急症呼吸衰竭与机械通气重症综合管理与镇静镇痛

高剂量硝酸甘油输注治疗交感崩溃性急性肺水肿的安全性与有效性描述:HI-DOSE SCAPE研究

High-dose nitroglycerin infusion description of safety and efficacy in sympathetic crashing acute pulmonary edema: The HI-DOSE SCAPE study.
PubMed 文献 · Am J Emerg Med · 2022-10-18
一句话结论在67例交感崩溃性急性肺水肿患者中,高剂量硝酸甘油输注(≥100 μg/min)可能是一种安全的替代间断弹丸式给药策略。

该研究为单中心描述性研究,纳入2018年1月1日至2018年12月31日急诊科接受高剂量硝酸甘油输注(≥100 μg/min)治疗交感崩溃性急性肺水肿的67例成人患者。起始中位收缩压211 mmHg,中位起始剂量100 mcg/min,第一小时中位峰值速率200 mcg/min,总体绝对最大速率400 μg/min。73%接受无创正压通气,ICU入住率37%,插管率21%,48小时急性肾损伤13%,低血压4%。作者认为高剂量硝酸甘油输注可能是间断弹丸式给药的 safe 替代策略。

要点

  • 高剂量硝酸甘油输注定义为≥100 μg/min,起始中位剂量100(100-200)mcg/min,第一小时中位峰值速率200(127.5-200)mcg/min,总体绝对最大速率400 μg/min。
  • 67例患者起始中位收缩压211(192-233)mmHg,63%男性,84%黑人,51%有心力衰竭史,36%有终末期肾病。
  • 73%接受无创正压通气,48%在高剂量输注前接受舌下或静脉弹丸式硝酸甘油,58%接受袢利尿剂,34%接受ACEI或ARB。
  • ICU入住率37%,插管率21%,48小时急性肾损伤13%,低血压4%。
  • 作者认为高剂量硝酸甘油输注可能是间断弹丸式高剂量硝酸甘油的安全替代策略。

适用人群与场景

  • 急诊科成人交感崩溃性急性肺水肿患者,接受高剂量硝酸甘油输注(≥100 μg/min)治疗。
  • 研究时段为2018年1月1日至2018年12月31日,地点为大型城市学术医疗中心急诊科。

处置流程与药物剂量

  • 高剂量硝酸甘油输注:起始中位剂量100(100-200)mcg/min,第一小时中位峰值速率200(127.5-200)mcg/min,总体绝对最大速率400 μg/min。
  • 73%患者接受无创正压通气(NIPPV)。
  • 48%患者在高剂量硝酸甘油输注前接受舌下或静脉弹丸式硝酸甘油。
  • 58%患者接受袢利尿剂。
  • 34%患者接受血管紧张素转换酶抑制剂(ACEI)或血管紧张素II受体阻滞剂(ARB)。

研究设计与关键结果

  • 研究类型为单中心描述性研究,纳入67例成人患者,接受高剂量硝酸甘油输注(≥100 μg/min)治疗交感崩溃性急性肺水肿。
  • 患者特征:63%男性,84%黑人,51%有心力衰竭史,36%有终末期肾病。
  • 起始中位(IQR)收缩压为211(192-233)mmHg。
  • 静脉硝酸甘油起始中位(IQR)剂量为100(100-200)mcg/min,第一小时中位(IQR)峰值速率为200(127.5-200)mcg/min,总体绝对最大观察速率为400 μg/min。
  • 73%患者接受无创正压通气,48%接受舌下或静脉弹丸式硝酸甘油,58%接受袢利尿剂,34%接受ACEI或ARB。
  • ICU入住率为37%,插管率为21%,48小时急性肾损伤发生率为13%,低血压发生率为4%。

证据类型、等级与局限

  • 证据类型:单中心描述性研究。
  • 作者结论:这是迄今为止描述高剂量硝酸甘油输注(≥100 μg/min)策略治疗交感崩溃性急性肺水肿的最大规模研究;高剂量硝酸甘油输注可能是间断弹丸式高剂量硝酸甘油的安全替代策略。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 对于急诊科交感崩溃性急性肺水肿成人患者,高剂量硝酸甘油输注(≥100 μg/min)可能是间断弹丸式高剂量硝酸甘油的替代策略(作者认为)。
  • 研究中高剂量硝酸甘油输注的起始中位剂量为100(100-200)mcg/min,第一小时中位峰值速率为200(127.5-200)mcg/min,总体绝对最大速率为400 μg/min。
  • 研究中73%患者同时接受无创正压通气,48%在高剂量输注前接受舌下或静脉弹丸式硝酸甘油,58%接受袢利尿剂,34%接受ACEI或ARB。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Sympathetic crashing acute pulmonary edema (SCAPE) is a medical emergency in which severe, acute elevation in blood pressure results in acute heart failure and fluid accumulation in the lungs. Without prompt recognition and treatment, the condition often progresses rapidly to respiratory failure necessitating intubation and intensive care unit (ICU) admission. In addition to non-invasive positive pressure ventilation (NIPPV), high-dose nitroglycerin (HDN) has become a mainstay of treatment; however, an optimal dosing strategy has not been established.

OBJECTIVE: The purpose of this study was to describe the characteristics and outcomes of patients who received an HDN infusion (≥ 100 μg/min) for the management of SCAPE in the Emergency Department (ED) of a large urban academic medical center. Outcomes were also analyzed to determine predictors of safety and efficacy including use of adjunct medication therapies.

RESULTS: There were 67 adult patients who received HDN infusion for SCAPE from January 1, 2018 to December 31, 2018. The median (IQR) systolic blood pressure (SBP) on initiation of HDN infusion was 211 (192-233) mmHg. Patients were 63% male, 84% black, 51% had a history of heart failure (HF), and 36% had end-stage renal disease (ESRD). IV nitroglycerin (NTG) was initiated at a median (IQR) dose of 100 (100-200) mcg/min with median (IQR) peak rate in the first hour of 200 (127.5-200) mcg/min and an absolute maximum observed rate of 400 μg/min overall. 73% of patients received NIPPV, 48% sublingual (SL) or IV bolus nitroglycerin before HDN infusion, 58% loop diuretic, and 34% angiotensin-converting enzyme inhibitor (ACEI) or angiotensin II receptor blocker (ARB). Rates of ICU admission, intubation, acute kidney injury (AKI) at 48 h, and hypotension were 37%, 21%, 13%, and 4% respectively.

CONCLUSION: This is the largest to date study describing the use of an HDN infusion (≥100 μg/min) strategy for the management of SCAPE. HDN infusion may be a safe alternative strategy to intermittent bolus HDN.

来源:Am J Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Houseman BS, Martinelli AN, Oliver WD, et al. High-dose nitroglycerin infusion description of safety and efficacy in sympathetic crashing acute pulmonary edema: The HI-DOSE SCAPE study. Am J Emerg Med. 2022. PMID: 36327753. doi:10.1016/j.ajem.2022.10.018

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。